FDA.reportPublic FDA data

Zavesca 100 MG Oral Capsule

RxCUI
541070
RxNorm name
Zavesca 100 MG Oral Capsule
Display name
Zavesca 100 MG Oral Capsule
Full name
Zavesca 100 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZavescaMIGLUSTATActelion Pharmaceuticals US, Inc.817892d1-ee12-4632-85fc-57ccdf16d7b82023-04-20Warnings, Adverse reactionsExact identifier
rxcui: 541070

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
817892d1-ee12-4632-85fc-57ccdf16d7b8Zavesca 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [Zavesca] [SBD] · Zavesca 100 MG Oral Capsule [SY]319These highlights do not include all the information needed to use ZAVESCA safely and effectively. See full prescribing information for ZAVESCA. ZAVESCA ® (miglustat) capsules, for oral use Initial U.S. Approval: 200320230420